-
Bristol-Myers Squibb
- Responsable des relations Externes
Rueil-Malmaison cedex
2013 - maintenant
-
BMS HQ EMEA
- Secondment Europe Market Research and Business Intelligence Director for Oncology
2012 - 2012
BMS EMEA HQ, RUEIL, FRANCE
On site secondment, close collaboration with Europe Market Research and Business Intelligence Director for Oncology
• Building assumptions and Forecast of Yervoy Launch excellence in EMEA region.
• Leading workshops to validate and endorse forecast assumptions and strategic planning with 28 BMS affiliates
• Presentations on Budget results and forecast out-puts for the region to EMEA & Global BMS Senior management
• Involved in all budget process steps on BMS EMEA region.
Strong Collaboration with BMS EMEA Marketing lead, Pricing and Market access lead, Oncology market research director, and BMS senior management.
-
IMS Health
- Senior consultant
PUTEAUX
2011 - 2013
IMS Health, PARIS, FRANCE
Senior Consultant, Marketing Excellence
• Designing solution-oriented methodologies and leading project execution
• Leading projects on various topics (Specialty care: launch excellence, port-folio management, KOL mapping, Hospital targeting, Promotional strategy, marketing initiatives return on investments, New commercial models, HPST Law impact on health care system)
• Lead workshops with senior managers and developing actionable recommendations
• Leading Focus group, and networking with KOL, Payers and health-care stakeholders (Oncology, Alzheimer disease, Hepatitis C and B...)
• Working on international assignments (USA, France, Germany, UK)
-
IMS Health
- Centre of excellence in Oncology, EMEA
PUTEAUX
2009 - 2010
- Project management in Oncology for key pharmaceutical company accounts
- Client account management in Oncology (marketing, market research, HEOR
- Financial and business development (sales pitch, proposal and contract
- Product development in Oncology in France (panel enhancement, sample validation, universe study, implementation and validation of projection methodology, PMSI, business cases
- Management of consulting project in oncology in prostate, breast, lung, melanoma cancer for key pharmas (data analysis, development of business strategies, portfolio and pipeline management, market assessment and forecasting)
- Member of innovation lab in specialty care market.
- Consulting school
-
Synovate, global tandem Oncology Monitor, London, UK
- Senior European Key account manager in oncology
2007 - 2009
- Management of key accounts (Sanofi HQ,MSD, etc..)
- Management of Ad-Hoc projects for key accounts to determine and ensure client objectives and deadline are met, onsite presentations and training.
- Presentations of results to client, organisation and lead of workshops and trainings, annual market review presentations, marketing strategies review presentations, sales pitch.
- Business case on new product development following asco or esmo guidelines, physician and clients feed-backs.
- Recruitment and management of a junior executive
- Point of reference for ad-hoc global team for all oncology related pojects
- New projection methodology development with data-process manager.
-
Cancer institute, UCL, London, UK
- Clinical and biomedical research project manager
2003 - 2007
- Research project creation and management in viral oncology: Analysis of Kaposi sarcoma herpes virus molecular signature implications in cancer signature.
- Creation, design, and writing of designated projects for a CRUK program grant application (funding successfully accepted), and of several scientific publications and abstracts for international meetings applications (cf list).
- Management of PhD students, interns and trainees.
- Peer-review activities for high impact factor journals (PLos pathogen, Nature medicine, Nature cancer genetics, cancer research, British journal of cancer), for fellowship grant funding (CRUK and Welcome trust)and research projects fundings (CRUK, EMBOj, Human frontiers) and for biotech drug companies (confidential), including analysis, evaluation, synthesis, final recomendation and mark.
- Partnership: clinical trials on Tarceva and Gleevec, in chemo naive NSCLC patients, building and management of sarcoma european database, with sanger institute, with Affymetrix on new GEM DNA Chip to facilitate diagnosis and treatment selection
- Award and funds: CRUK funding
